The human genetic variant rs6190 unveils Foxc1 and Arid5a as novel prometabolic targets of the glucocorticoid receptor in muscle
Science Advances · 2025
DOI: 10.1126/sciadv.adw2593 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Ashok Daniel Prabakaran und 9 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Cardiovascular Biology, Heart Institute, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinna…. Hauptthemen laut MEDLINE: Receptors, Glucocorticoid, Muscle, Skeletal, Forkhead Transcription Factors, Transcription Factors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
The mechanisms segregating positive from negative effects of the glucocorticoid receptor (GR) on metabolic health remain poorly elucidated. Here, we generated mice genocopying the human GR polymorphism rs6190, which was sufficient to increase muscle insulin sensitivity and blunt obesity-induced adverse effects on adiposity and exercise intolerance. We identified Foxc1 and Arid5A genes as prospective transactivation targets by the mutant GR in skeletal muscle. In the muscle, we further characterize Foxc1 as transcriptional activator of Insr and Irs1 in the canonical insulin signaling and Arid5a as transcriptional repressor of Cd36 and Fabp4 in the lipid uptake pathway. Moreover, Foxc1 and Arid5a programs in muscle were divergently changed by glucocorticoid regimens with opposite metabolic outcomes. Last, in the UK Biobank and All of Us datasets, the rs6190 variant correlated with prometabolic changes in BMI, lean mass, strength, and glucose control according to zygosity. Collectively, our study leveraged a human nuclear receptor coding variant to unveil epigenetic regulators of muscle metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular Cardiovascular Biology, Heart Institute, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
- Department of Pharmacology, Physiology, and Neurobiology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
- Stem Cell Laboratory, Department of Pathophysiology and Transplantation, Dino Ferrari Centre, Università degli Studi di Milano, Milan, Italy.
ORCID-Profile: Ashok Daniel Prabakaran, Thirupugal Govindarajan, Hannah Latimer, Olukunle Akinborewa, Chiara Villa, Douglas P Millay, Mattia Quattrocelli
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Prabakaran, A. D., Montecino-Morales, F., McFarland, K., Govindarajan, T., Durumutla, H. B., Latimer, H., Akinborewa, O., Villa, C., Millay, D. P., & Quattrocelli, M. (2025). The human genetic variant rs6190 unveils Foxc1 and Arid5a as novel prometabolic targets of the glucocorticoid receptor in muscle. Science Advances. https://doi.org/10.1126/sciadv.adw2593
Vancouver
Prabakaran AD, Montecino-Morales F, McFarland K, Govindarajan T, Durumutla HB, Latimer H, et al. The human genetic variant rs6190 unveils Foxc1 and Arid5a as novel prometabolic targets of the glucocorticoid receptor in muscle. Science Advances. 2025. doi:10.1126/sciadv.adw2593
BibTeX
@article{Prabakaran2025,
author = {Prabakaran, Ashok Daniel and Montecino-Morales, Fabian and McFarland, Kevin and Govindarajan, Thirupugal and Durumutla, Hima Bindu and Latimer, Hannah and Akinborewa, Olukunle and Villa, Chiara and Millay, Douglas P and Quattrocelli, Mattia},
title = {The human genetic variant rs6190 unveils Foxc1 and Arid5a as novel prometabolic targets of the glucocorticoid receptor in muscle},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adw2593}
}
EUVIMED